Clinical Trials Directory

Trials / Completed

CompletedNCT02885129

Development of the General Scale Observance for Chronic Diseases

Development of the General Scale Observance for Chronic Diseases (EGOMAC)

Status
Completed
Phase
Study type
Observational
Enrollment
397 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main objective is to assess the measurement characteristics (validity, reproducibility) and the invariance of EGOMAC scale in a population of consultants in diabetology, cardiology and rheumatology hospital and liberal and hospital oncology and Infectious disease, by following the evolution of patient compliance at D0 and D15. The second objective is to assess the sensitivity to change of scale EGOMAC following developments compliance 3 months.

Detailed description

During a routine appointment (D0), the patient filled a newsletter and a questionnaire to complete. The doctor collects medical informations for the case report form. At the end of the first consultation (D0), an additional EGOMAC scale and a stamped envelope is delivered to the patient by asking him to fill that scale to 15 days and return it by Post Office (reproducibility study). Finally, a new scale will be addressed to the patient at the end of 3 months, which will return by Post Office too (stability study).

Conditions

Timeline

Start date
2014-06-01
Primary completion
2017-04-01
Completion
2017-04-01
First posted
2016-08-31
Last updated
2017-08-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02885129. Inclusion in this directory is not an endorsement.

Development of the General Scale Observance for Chronic Diseases (NCT02885129) · Clinical Trials Directory